$RTRX Travere Therapeutics, Inc. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Travere Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in Travere Therapeutics, Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
Travere Therapeutics, Inc. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| ASELAGE STEVE | Director | 198,940 | 3,992,726 | Apr 20 2021 | |||
| ASELAGE STEVE | Chief Executive Officer | 371,756 | 7,461,143 | Nov 21 2014 | |||
| ASELAGE STEVE | President and COO | 261,756 | 5,253,443 | Jun 03 2014 | |||
| Baynes Roy D. | Director | 14,000 | 280,980 | May 19 2020 | |||
| Bruhn Suzanne Louise | Director | 5,250 | 105,368 | Apr 09 2020 | |||
| Clague Laura | Chief Financial Officer | 30,223 | 606,576 | May 13 2021 | |||
| Clague Laura | Chief Financial Officer | 0 | 0 | Nov 17 2014 | |||
| Coughlin Timothy P | Director | 32,000 | 642,240 | May 19 2020 | |||
| Dube Eric M | Chief Executive Officer | 161,626 | 3,243,834 | Feb 09 2021 | |||
| Golding Cornelius E | Director | 29,000 | 582,030 | May 19 2016 | |||
| Golding Cornelius E | Director | 3,000 | 60,210 | Dec 27 2013 | |||
| Golding Cornelius E | Director | 25,000 | 501,750 | Nov 19 2014 | |||
| Heerma Peter | Chief Commercial Officer | 61,594 | 1,236,192 | Feb 05 2021 | |||
| KOZARICH JOHN W | Director | 29,000 | 582,030 | May 10 2019 | |||
| LYONS GARY A | Director | 37,000 | 742,590 | May 18 2021 | |||
| LYONS GARY A | Director | 20,000 | 401,400 | Oct 10 2014 | |||
| McFarlane Neil F. | Chief Operating Officer | 27,972 | 561,398 | May 16 2019 | |||
| Meckler Jeffrey A | Director | 67,000 | 1,344,690 | May 18 2021 | |||
| Meckler Jeffrey A | Director | 35,000 | 702,450 | Nov 25 2014 | |||
| Orwin John A | Director | 11,875 | 238,331 | May 19 2020 | |||
| Paley Jeffrey | Director | 51,665 | 1,036,917 | Aug 18 2014 | |||
| PANOFF MARC L | Chief Financial Officer | 221,100 | 4,437,477 | Feb 28 2014 | |||
| Plotkin Horacio | Chief Medical Officer | 102,200 | 2,051,154 | Aug 12 2014 | |||
| Plotkin Horacio | Chief Medical Officer | 91,767 | 1,841,764 | Dec 16 2014 | |||
| Poole Sandra | Director | 6,500 | 130,455 | May 19 2020 | |||
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 42,205 | 847,054 | Feb 05 2021 | |||
| Richardson Steven Gary | Director | 99,165 | 1,990,242 | Dec 30 2013 | |||
| Richardson Steven Gary | Director | 129,165 | 2,592,342 | Nov 24 2014 | |||
| Rosenberg Noah L. | Chief Medical Officer | 45,969 | 922,598 | May 13 2021 | |||
| ROTE WILLIAM E. | Senior Vice President, R&D | 33,269 | 667,709 | May 13 2021 | |||
| Shih Alvin | EVP of Research & Development | 158,334 | 3,177,763 | Sep 02 2016 | |||
| Shkreli Martin | Chief Executive Officer | 2,666,246 | 53,511,557 | Dec 10 2013 | |||
| Shkreli Martin | Chief Executive Officer | 2,995,148 | 60,112,620 | Oct 09 2014 | |||
| Shkreli Martin | 1,765,168 | 35,426,922 | Nov 24 2014 | ||||
| Squarer Ron | Director | 14,875 | 298,541 | May 18 2021 | |||
| VALEUR JENSEN MARGARET E | General Counsel | 100,000 | 2,007,000 | Feb 02 2016 | |||
| VALEUR JENSEN MARGARET E | General Counsel | 100,000 | 2,007,000 | Nov 17 2014 |